NEWS AND EVENTS

  Palma, Spain and San Diego, USA, July 17, 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, will present at the European Biotech Investor Day in NYC, organized by Solebury Trout, Goodwin LLC and Nasdaq. Sanifit will present at 3.00 PM on Thursday, July 19. Dr Joan Perelló, […]

Read more

Palma, Spain and San Diego, USA 25th May 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, announced that the results of its Phase 2 clinical trial of SNF472 were presented during an oral session earlier today at the 55th ERA-EDTA Congress taking place in Copenhagen, Denmark. The presentation […]

Read more

The international magazine CEO Today has published a list with the 100 Europe’s most talented Chief Executive Officers whose commitment to excellence and achievements are worth cheering for. Every year CEO Today Magazine identifies and honors the most progressive, forward-thinking and ambitious company leaders in todays’ business. The CEO Today team collate votes and in-depth […]

Read more

Palma, Spain and San Diego, USA March 06, 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, announced today the completion of its Phase II clinical trial of SNF472, its lead candidate for the treatment of the orphan disease calciphylaxis (calcific uraemic arteriolopathy, CUA), with both primary and secondary […]

Read more

Palma, Spain, and San Diego, USA, January 8, 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the appointment of Cris Calsada as Chief Financial Officer. Ms. Calsada joins Sanifit with over 20 years of corporate finance and executive experience in the life sciences and technology industries. […]

Read more